KCT0006201尚未招募未知
An open, randomized, multicenter, prospective comparative study to verify the usefulness and safety of endoscopic sphincterotomy using modified sphincterotome (OptimosTM) and foreign-made sphincterotome (CleverCut3V)
Yonsei University Health System, Gangnam Severance Hospital0 个研究点目标入组 104 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 104
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 19?(Year) 至 0No Limit（—）
- 性别
- All
入选标准
- •1. Patients with original biliary papilla
- •2. Patients with or suspected of having biliary tract disease
- •3. Patients in need of endoscopic retrograde cholangiopancreatography for treatment
排除标准
- •1.Under 19
- •2.Pregnant patients
- •3. Patients with reduced intelligence
- •4. Patients sensitive to contrast agents
- •5.Patients who had previously undergone papillary incision
- •6.Biliary papillary tumor patients
- •7.Patients who underwent hepatobiliary surgery
- •8.Patients who have difficulty endoscopically accessing the biliary papilla due to abdominal surgery (eg, gastrectomy, total gastrectomy)
研究者
相似试验
招募中
3 期
A comparative clinical trial to test efficacy and safety of 2 brands of highly purified follicle-stimulating hormone in subjects undergoing IVFCTRI/2010/091/000852Bharat Serums and Vaccines Limited100
招募中
3 期
A comparative clinical trial to test efficacy and safety of 2 brands of highly purified human menopausal gonadotropins in subjects undergoing their first cycle of IVFCTRI/2009/091/000854Bharat Serums and Vaccines Limited100
招募中
1 期
A multi-centre, open, prospective, randomized, parallel-group, 24-month study to compare the outcome of receiving continued immunosuppression versus stopping immunosuppression at 6 months to safely prevent human leukocyte antigen (HLA) sensitization in patients with late renal graft failureRenal transplantationCTIS2023-506879-98-00Vall D'hebron Institut De Recerca202
进行中（未招募）
不适用
An open, randomised, prospective, multi-centre, parallel-group trial to compare efficacy and safety of TachoSil versus standard surgical treatment in patients undergoing pulmonary lobectomy for lung malignancy and requiring treatment for air leakage - TachoSil versus standard surgical treatment for air leakage in pulmonary lobectomyEUCTR2004-002380-24-ITYCOMED HEADQUARTER300
进行中（未招募）
不适用
An open randomised, prospective, multi-centre, parallel-group trial to compare efficacy and safety of TachoSil versus standard surgical treatment in patients undergoing pulmonary lobectomy for lung malingnancy and requiring treatment for air leakage. - TachoSil versus standard surgical treatment for air leakage in pulmonary lobectomyManagement of pulmonary air leakage following lobectomy in subjects with lung malignancies including metastases.MedDRA version: 8.1Level: PTClassification code 10024741EUCTR2004-002380-24-HUycomed Danmark ApS, International Medical Affairs300